Ravicti
Payments companies reported to CMS as associated with Ravicti. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ravicti, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ravicti
These are the largest totals companies reported as associated with Ravicti. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stephanie Offord | Milwaukee, WI | Family | $38,711.00 |
| Amarilis Sanchez Valle | Tampa, FL | Clinical Genetics (M.D.) | $23,794.90 |
| Markey Mcnutt | Dallas, TX | Clinical Genetics (M.D.) | $18,835.30 |
| Vernon Sutton | Houston, TX | Pediatrics | $18,145.54 |
| Damara Gutnick | New York, NY | Internal Medicine | $16,485.37 |
| Barbara Burton | Chicago, IL | Clinical Genetics (M.D.) | $16,470.07 |
| Can Ficicioglu | Philadelphia, PA | Clinical Genetics (M.D.) | $14,867.54 |
| Neena Champaigne | Charleston, SC | Clinical Genetics (M.D.) | $12,103.87 |
| Andrea Gropman | Washington, DC | Neurology With Special Qualifications In Child Neurology | $10,752.24 |
| Erika Vucko | Chicago, IL | Nurse Practitioner | $10,691.71 |
Prescribed Ravicti?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.